Australia markets closed

Santhera Pharmaceuticals Holding AG (SPHDF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
11.700.00 (0.00%)
At close: 01:23PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,162
7,473
-1,595
15,008
Cost of revenue
3,645
3,592
3,767
10,431
Gross profit
1,517
3,881
-5,362
4,577
Operating expenses
Research development
23,414
30,536
29,715
34,228
Selling general and administrative
24,980
25,422
22,057
23,914
Total operating expenses
48,262
55,857
51,526
57,653
Operating income or loss
-46,745
-51,976
-56,888
-53,076
Interest expense
19,852
20,189
16,423
6,891
Income before tax
-64,904
-70,616
-54,717
-67,456
Income tax expense
-216
460
809
203
Income from continuing operations
-64,688
-71,076
-55,526
-67,659
Net income
-64,688
-71,076
-55,526
-67,659
Net income available to common shareholders
-64,688
-71,076
-55,526
-67,659
Basic EPS
-8.63
-11.70
-16.20
-50.80
Diluted EPS
-8.63
-11.70
-16.20
-50.80
Basic average shares
8,837
6,093
3,417
1,332
Diluted average shares
8,837
6,093
3,417
1,332